The majority of Teva's business lies in generic and off-patent branded drugs which faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...

The panel was part of the 47th annual Sapics Conference, attended by more than 700 supply chain professionals from across ...

Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ETCompany ParticipantsAnn M. Dennison - Executive VP & CFOBrian C.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Cencora (COR), which belongs to the Zacks ...

But as she explained, African-led innovators are working to close these gaps through technology, data and new business models ...

In the first part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of supply chain operations & ...

July 7 – With a 90-day negotiating period on country-specific US tariffs is set to expire on July 9, Trump enacts a multitude ...

Steve Collis’ three decades of experience at a major drug distributor could prove helpful for Elevance as it continues to ...

GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

Florida’s importation program hasn’t brought in a single Canadian drug. It’s not cost-effective and it could be dangerous.

We came across a bullish thesis on Cencora, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize ...